Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: A randomized, prospective, double-blind study

Journal of Cardiovascular Medicine

Volumn 7, Issue 2, 2006, Pages 119-123

  Fattouch, Khalil ^a,c   Sbraga, Fabrizio ^a   Sampognaro, Roberta ^a   Bianco, Giuseppe ^a   Gucciardo, Marco ^a   Lavalle, Carlo ^b   Vizza, Carmine Dario ^b   Fedele, Francesco ^b   Ruvolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Cardiac surgical procedures; Nitric oxide; Prostacyclin; Pulmonary hypertension; Right ventricular function; Vasodilators

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN; VASODILATOR AGENT; ANTIHYPERTENSIVE AGENT; BRONCHODILATING AGENT;

ADULT; AGED; ARTERY CATHETER; ARTICLE; CARDIOPULMONARY BYPASS; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART SURGERY; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SWAN GANZ CATHETER; COMPARATIVE STUDY; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; LENGTH OF STAY; MIDDLE AGED;

ADMINISTRATION, INHALATION; AGED; ANTIHYPERTENSIVE AGENTS; BRONCHODILATOR AGENTS; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; EPOPROSTENOL; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; LENGTH OF STAY; MIDDLE AGED; MITRAL VALVE STENOSIS; NITRIC OXIDE; PROSPECTIVE STUDIES;

EID: 33646825344     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000203850.97890.fe     Document Type: Article

References (23)

1. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg 2000; 69:823-828.
2. Lesage AM, Tsuchioka H, Young WG Jr, Sealy WC. Pathogenesis of pulmonary damage during extracorporeal perfusion. Arch Surg 1966; 93:1002-1008.
3. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992; 19:48-54.
4. Speziale G, De Biase L, De Vincentis G, Lerardi M, Ruvolo G, La Francesca S, et al. Inhaled nitric oxide in patients with severe heart failure: changes in lung perfusion and ventilation detected using scintigraphy. Thorac Cardiovasc Surg 1996; 44:35-39.
5. Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988; 11:917-921.
6. Downing SW, Edmunds LH Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992; 54:1236-1243.
7. Ruvolo G, Speziale G, Greco E, Tritapepe L, Mollace V, Nistico G, Marino B. Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1995; 9:651-654.
8. Speziale G, Ruvolo G, Marino B. A role for nitric oxide in the vasoplegic syndrome. J Cardiovasc Surg (Torino) 1996; 37:301-303.
9. Ruvolo G, Greco E, Speziale G, Tritapepe L, Marino B, Mollace V, Nistico G. Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 1994; 57:1055-1057.
10. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 1998; 114:780-786.
11. Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller m, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154 (Pt 1):1671-1677.
12. Van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000; 117:819-827.
13. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124:820-824.
14. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342:961-962.
15. Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to endstage heart failure. Am J Cardiol 1998; 82:749-755.
16. Rich S, McLaughlin VV. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 1999; 34:1184-1187.
17. Girard C, Lehot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77:880-883.
18. Moraes D, Loscalzo J. Pulmonary hypertension: newer concepts in diagnosis and management. Clin Cardiol 1997; 20:676-682.
19. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88 (Pt 1):2128-2138.
20. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993; 106:473-478.
21. Haraldsson A, Kieler-Jensen N, Ricksten SE. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 1996; 10:864-868.
22. Haraldsson A, Kieler-Jensen N, Wadenvik H, Ricksten SE. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Intensive Care Med 2000; 26:188-194.
23. Olschewski H, Ghofrani A, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 1999; 160:600-607.